Imatinib for the treatment of patients with unresectable and/or metastatic gastrointestinal stromal tumours: systematic review and economic evaluation

• 1 July 2005
• journal article
• review article
• Published by National Institute for Health and Care Research in Health Technology Assessment
• Vol. 9  (25) , 1-142
• https://doi.org/10.3310/hta9250

Abstract

Keywords

• TREATMENT
• IMATINIB
• TUMOURS
• STROMAL
• UNRESECTABLE
• METASTATIC
• PUBLISHED
• ASSESSMENT VOLUME
• HEALTH TECHNOLOGY
• EVALUATION HEALTH

Funding Information

• Health Technology Assessment Programme (03/01/01)